Edition:
United States

Oxford Immunotec Global PLC (OXFD.OQ)

OXFD.OQ on NASDAQ Stock Exchange Global Market

13.75USD
21 May 2018
Change (% chg)

-- (--)
Prev Close
$13.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
48,415
52-wk High
$19.50
52-wk Low
$10.26

Select another date:

Tue, May 1 2018

BRIEF-Oxford Immunotec Reports Q1 Loss Per Share $0.40

* OXFORD IMMUNOTEC REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Oxford Immunotec Q4 Earnings Per Share $0.33

* OXFORD IMMUNOTEC REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-James Flynn Reports 5.1 Pct Passive Stake In Oxford Immunotec Global Plc As Of Jan 22

* JAMES FLYNN REPORTS 5.1 PERCENT PASSIVE STAKE IN OXFORD IMMUNOTEC GLOBAL PLC AS OF JANUARY 22 - SEC FILING Source text: [http://bit.ly/2BNPx1n] Further company coverage:

BRIEF-Oxford Immunotec Announces Preliminary Revenue For Q4

* FY2017 REVENUE VIEW $104.1 MILLION -- THOMSON REUTERS I/B/E/S

Qiagen to pay Oxford Immunotec $27.5 million to settle patent case

Qiagen NV said on Friday it had agreed to pay $27.5 million to resolve a lawsuit claiming that a tuberculosis blood test it produces infringes patents held by competitor Oxford Immunotec Global PLC.

BRIEF-Oxford Immunotec And Qiagen Reached A Settlement In Lawsuit

* OXFORD IMMUNOTEC GLOBAL - CO, QIAGEN REACHED A SETTLEMENT IN LAWSUIT IN U.S. COURT ALLEGING PATENT INFRINGEMENT IN RELATION TO QIAGEN'S PRODUCTS

Select another date: